Ionis Pharmaceuticals Inc
XBER:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
XBER:ISI
|
US |
|
Alpha Services and Holdings SA
F:ACBC
|
GR |
|
Sun Life Financial Inc
TSX:SLF
|
CA |
|
Astrindo Nusantara Infrastruktur Tbk PT
IDX:BIPI
|
ID |
|
C
|
Cheesecake Factory Inc
DUS:CF2
|
US |
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
Wall St Price Targets
ISI Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ISI is 84.07 EUR with a low forecast of 37.39 EUR and a high forecast of 109.84 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISI's stock price target?
Price Target
84.07
EUR
According to Wall Street analysts, the average 1-year price target for ISI is 84.07 EUR with a low forecast of 37.39 EUR and a high forecast of 109.84 EUR.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.
What is the Gross Profit forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
